ELV

Elevance Health Inc.

Healthcare · $85.1B market cap

Verdict

Share price

$386.43

close of Oct 3, 2026

Fair value

$314.33

Sticker Price

Payback Price

$125.73

buy price

Overpriced

ELV is Overpriced: at $386.43 it trades 23% above its fair value of $314.33. Its buy price (Payback Price) is $125.73, 67% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.

How we valued it

Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth4.8% a year✗
Equity per share growth8.5% a year✗
Sales growth7.0% a year✗
Free cash flow growth4.4% a year✗
Return on invested capital6.9%✗

Follow ELV

Get notified when it reaches its buy price of $125.73. Free.

Create a free account

Superinvestors

11 of the investors we track hold ELV. In Q2 2026, 1 opened a position, 1 added and 3 trimmed. Who we track

Moves in Q2 2026

New position: Harry Burn

Added: Tweedy Browne

Trimmed: Ruane Cunniff LP, Vulcan Value Partners, Glenn Greenberg

Insider activity

Since Jun 12, 2026: 3 open-market purchases worth $1.4M, 1 sale worth $149K and 3 other filings (stock awards, tax withholding and similar). Why purchases matter

Purchases

Sales

Other filings

About Elevance Health Inc.

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical…

Medical - Healthcare Plans

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works